Prof. Dr. Peter Loskill

After completing his PhD at Saarland University in 2012, he went to Berkeley, CA, USA, for three years as a postdoc. He then spent 5 years as Attract group leader at Fraunhofer IGB, Stuttgart before joining the NMI in 2021 and has been group leader of the Organ-on-Chip group since then. His research interests include organ-on-chip, tissue engineering, and microfabrication.

Selected publications

• Autologous human immunocompetent white adipose tissue-on-chip. Adv. Sci., 2022, DOI: 10.1002/202104451
• Human stem cell-based retina-on-chip as new translational model for validation of AAV retinal gene therapy vectors. Stem Cell Rep., 2021, DOI: 10.1016/2021.08.008
• Peristaltic on-chip pump for tunable media circulation and whole blood perfusion in PDMS-free organ-on-chip and Organ-Disc systems. Lab Chip, 2021, DOI: 10.1039/C00494H
• Non-invasive marker-independent high content analysis of a microphysiological human pancreas-on-a-chip model. Matrix Biol., 2020, DOI: 10.1016/.2019.06.008
• Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human Retina-on-a-Chip platform. eLife, 2019, DOI: 10.755446188

ORCID: 0000-0002-5000-0581